Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma.
Xu ZhangShuai PingAnni WangCan LiRui ZhangZimu SongCaibin GaoFeng WangPublished in: International journal of general medicine (2021)
The IRGP signature demonstrated good prognostic value for Grade II/III gliomas, which may provide new insights into individual treatment for glioma patients. The IRGPs might function through the identified 26 functional pathways.